(a) A substance shall be placed in schedule IVA if it is found under AS 11.71.120(c) to have a degree of danger or probable danger to a person or the public which is less than the substances listed in schedule IIIA, but higher than the substances listed in schedule VA.
(b) Schedule IVA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) barbital;
(2) chloral betaine;
(3) chloral hydrate;
(4) chlordiazepoxide;
(5) clonazepam;
(6) clorazepate;
(7) diazepam;
(8) ethclorvynol;
(9) ethinamate;
(10) flurazepam;
(11) lorazepam;
(12) mebutamate;
(13) meprobamate;
(14) methohexital;
(15) methylphenobarbital, also known as mephobarbital;
(16) oxazepam;
(17) paraldehyde;
(18) petrichloral;
(19) phenobarbital;
(20) prazepam;
(21) alprazolam;
(22) halazepam;
(23) temazepam;
(24) triazolam;
(25) midazolam;
(26) quazepam;
(27) flunitrazepam;
(28) ketamine hydrochloride.
(c) Schedule IVA includes any material, compound, mixture or preparation which contains any quantity of the following substance, including its salts, isomers whether optical, position, or geometric, and salts of these isomers, whenever the existence of these salts, isomers, and salts of isomers is possible: fenfluramine.
(d) Schedule IVA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers whether optical, position, or geometric, and salts of these isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) diethylpropion;
(2) phentermine;
(3) pemoline, including organometallic complexes and chelates of this substance;
(4) mazindol;
(5) pipradol;
(6) SPA ((-)-1-dimethylamino-1,2-diphenylethane);
(7) cathine;
(8) fencamfamin;
(9) fenproporex;
(10) mefenorex.
(e) Schedule IVA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or their salts calculated as the free anhydrous base or alkaloid.
(f) Schedule IVA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including their salts:
(1) dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-dephenyl-3-methyl-2-propionoxybutane);
(2) pentazocine;
(3) propoxyphene.
(g) Schedule IVA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substance or its salts calculated as the free anhydrous base or alkaloid: 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers, including tramadol.